Robert McWhirterAlgernon Pharmaceuticals Inc.AGN.VHOLDMay 29, 2020

It produces a drug that has been repurposed for anti-anxiety in Japan. When you look at COVID-19 and its related illnesses, the drug can be used to help with chronic cough and pneumonia. Their chronic cough trial is going into Phase II in Australia. He owns it personally.

Robert McWhirter

Owned

Unlock Rating

N/A

Stock price when the opinion was issued

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Wealthica Track your Stocks in your Watch List

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Robert McWhirterAlgernon Pharmaceuticals Inc.AGN.VHOLDMay 29, 2020

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals